Endocrine treatment: expected duration stage by stage.
Schröder
F H
FH
Department of Urology, Academic Hospital and Erasmus University, Rotterdam, The Netherlands. vanalphen@urol.azr.nl
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018450:Disease Progression; D004967:Estrogens / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000601:surgery / Q000628:therapy*; D013997:Time Factors
D000726:Androgen Antagonists; D004967:Estrogens; D017430:Prostate-Specific Antigen